米非司酮联合米索前列醇应用于剖宫产术后1年内中期妊娠中孕期引产安全性分析  

Safety analysis of mifepristone combined with misoprostol in the second trimester odinopoeia of pregnant women within1-year after cesarean section

作　　者：郜丽敏[1] 张晓平[1] 刘永莹[1] 

机构地区：[1]安徽省阜阳市人民医院妇产科,236000

出　　处：《蚌埠医学院学报》2015年第9期1186-1188,共3页Journal of Bengbu Medical College

摘　　要：目的:探讨剖宫产术后1年内中期妊娠应用米非司酮联合米索前列醇药物引产的效果。方法:观察组为剖宫产术后1年内中期妊娠引产24例,对照组为剖宫产术后2年以上中期妊娠引产30例,均给予米非司酮联合米索前列醇引产。结果:2组在引产成功率、应用米索前列醇总量、应用米索前列醇至胎儿娩出时间、阴道流血量、胎盘残留、住院时间、宫颈裂伤发生率差异均无统计学意义(P>0.05)。结论:米非司酮联合米索前列醇应用于剖宫产术后1年内中期妊娠引产临床效果安全可靠。Objective：To explore the effects of mifepristone combined with misoprostol in the second trimester odinopoeia of pregnant women within 1-year after cesarean section. Methods：The second trimester odinopoeia women within 1-year after cesarean section in 24 cases and more than 2 years after cesarean section in 30 cases were divided into the experimental group and control group,respectively. Two groups were induced labor with mifepristone combined with misoprostol. Results：The differences of the success rate, dosage of misoprostol,time from the use of misoprostol to labor, amount of vaginal bleeding, placental residue, length of stay and incidence of cervical laceration were not statistical significance（P〉0. 05）. Conclusions：The effects of mifepristone combined with misoprostol in the second trimester odinopoeia of pregnant women within 1-year after cesarean section are safe and reliable.

关 键 词：剖宫产 米非司酮 米索前列醇 引产 

分 类 号：R719.8[医药卫生—妇产科学]